Biotricity, Inc. (BTCY)
Total Valuation
Biotricity has a market cap or net worth of $7.10 million. The enterprise value is $27.57 million.
Market Cap | 7.10M |
Enterprise Value | 27.57M |
Important Dates
The last earnings date was Tuesday, November 14, 2023, after market close.
Earnings Date | Nov 14, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
Biotricity has 8.77 million shares outstanding. The number of shares has increased by 1.77% in one year.
Shares Outstanding | 8.77M |
Shares Change (YoY) | +1.77% |
Shares Change (QoQ) | +0.49% |
Owned by Insiders (%) | 18.54% |
Owned by Institutions (%) | 5.42% |
Float | 7.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.67 |
Forward PS | 0.99 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.48 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.29
Current Ratio | 0.29 |
Quick Ratio | 0.17 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.01 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -261.60% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $202,067 |
Profits Per Employee | -$310,687 |
Employee Count | 55 |
Asset Turnover | 1.70 |
Inventory Turnover | 2.14 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.32% in the last 52 weeks. The beta is 2.35, so Biotricity's price volatility has been higher than the market average.
Beta (1Y) | 2.35 |
52-Week Price Change | -87.32% |
50-Day Moving Average | 1.63 |
200-Day Moving Average | 2.89 |
Relative Strength Index (RSI) | 27.75 |
Average Volume (30 Days) | 23,804 |
Short Selling Information
The latest short interest is 141,139, so 1.61% of the outstanding shares have been sold short.
Short Interest | 141,139 |
Short Previous Month | 135,095 |
Short % of Shares Out | 1.61% |
Short % of Float | 2.01% |
Short Ratio (days to cover) | 4.30 |
Income Statement
In the last 12 months, Biotricity had revenue of $11.11 million and -$17.09 million in losses. Loss per share was -$1.96.
Revenue | 11.11M |
Gross Profit | 6.85M |
Operating Income | -11.01M |
Pretax Income | -16.29M |
Net Income | -17.09M |
EBITDA | -12.52M |
EBIT | -13.04M |
Loss Per Share | -$1.96 |
Balance Sheet
The company has $1.28 million in cash and $21.40 million in debt, giving a net cash position of -$20.12 million or -$2.29 per share.
Cash & Cash Equivalents | 1.28M |
Total Debt | 21.40M |
Net Cash | -20.12M |
Net Cash Per Share | -$2.29 |
Equity / Book Value | -26.73M |
Book Value Per Share | -3.05 |
Working Capital | -12.65M |
Cash Flow
Operating Cash Flow | -9.28M |
Capital Expenditures | n/a |
Free Cash Flow | -9.28M |
FCF Per Share | -$1.06 |
Margins
Gross margin is 61.66%, with operating and profit margins of -99.02% and -153.75%.
Gross Margin | 61.66% |
Operating Margin | -99.02% |
Pretax Margin | -146.60% |
Profit Margin | -153.75% |
EBITDA Margin | -112.61% |
EBIT Margin | -117.33% |
FCF Margin | -83.50% |
Dividends & Yields
Biotricity does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -229.24% |
FCF Yield | -124.49% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.77% |
Shareholder Yield | -1.77% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | Hold |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 3, 2023. It was a reverse split with a ratio of 1:6.
Last Split Date | Jul 3, 2023 |
Split Type | Reverse |
Split Ratio | 1:6 |
Scores
Biotricity has an Altman Z-Score of -31.39 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -31.39 |
Piotroski F-Score | 4 |